Henry Goebe

Henry Goebe has extensive experience in drug development and clinical safety, beginning with a tenure at the NHS from August 1996 to December 2000, where expertise was gained in Internal Medicine and its subspecialties. At Daiichi Sankyo from January 2001 to November 2004, Henry served as the European Project Leader for two New Chemical Entities, including Prasugrel (Effient). Since December 2004, Henry has held the position of Senior Director, Clinical Safety and Risk Lead at Pfizer, directing risk management strategies and leading a matrix team while providing strategic guidance and recommendations to internal and external stakeholders. Henry obtained an MD in Medicine from Technische Universität Dresden between 1990 and 1996.